or
Bookmark and Share
Use of citrate-containing dialysate for renal dialysis treatment
 
   
Document Number
US Patent 6566402
Issued Date
May 20, 2003
Link
Inventors
Map
Abstract
The present invention describes trisodium citrate-containing dialysates and production thereof. Also described are the applications of such dialysates as regional anticoagulants during hemodialysis and all modes of continuous renal replacement therapy which utilize any form of dialysis.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
6
Comments:
no comments yet
Owner
UAB Research Foundation (Birmingham, AL)
Published
May 20, 2003
Application Number
09/863,657
Filed
May 23, 2001
US Classification
514/574  
Int'l Classification
A61K   31/185   (20060101)   A61K   31/194   (20060101)   A61K   31/19   (20060101)  
Examiner
Attorney/Law Firm
Parent Case
CROSS-REFERENCE TO RELATED APPLICATION This non-provisional patent application claims benefit of provisional U.S. Ser. No. 60/206,763, filed May 24, 2000, now abandoned.
USPTO Field of Search
514/574  
Related Patents
7029456 - Medical fluid therapy flow balancing and synchronization system - Owned by Baxter International Inc. (Deerfield, IL) Baxter Healthcare S.A. (Zurich,CH)

Systems, apparatus and methods that allow external infusion, IV or administration pumps to be synchronized with the internal pumps for a medical fluid therapy machine are provided. The system reduces the time and effort needed to calculate, set-up, enter and maintain flowrates of various fluids, maintained internally or externally with respect to the medical fluid therapy machine. The system also automatically follows therapy requirements, for example, a requirement that one pump/fluid be running/flowing for another pump/fluid to be enabled to run/flow. The system further automatically adjusts for variations in flowrate of one fluid with respect to another. In short, the system provides a more "hands-off", safe and effective method and apparatus for medical fluid therapy fluid delivery.

7544301 - Citrate-based dialysate chemical formulations - Owned by HHD LLC (Manchester, NH)

The present invention constitutes dialysate formulations that are suitable for use in preparing dialysate solutions for use in batch and/or proportioning systems and for improving dialysis efficiency by reducing or preventing clotting of the dialysis flow paths. The dialysate chemical formulations for one batch of dialysate comprise an acid concentrate stored in a first vessel, and a citrate-containing bicarbonate concentrate stored in a second vessel. The contents of the first and second vessels are emptied into a dialysate preparation tank and mixed with water to form a batch quantity of dialysate solution. Alternately, a dry acid and/or a dry citrate-containing base concentrates are dissolved separately in measured quantities of water to form liquid concentrates which are then used in conjunction with a proportioning machine to generate on-line a final dialysis solution stream.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us